MAGEA1 and cancer: The first member of the cancer testis antigen family (CTAs), MAGE-1 (renamed to MAGEA1), was defined by T. Boon’s laboratory in early 1990s as a target for T-cell attack, initially in melanoma but then also in other cancers [124].